Drugs in the aetiology of agranulocytosis and aplastic anaemia.

Kaufman, D W; Kelly, J P; Jurgelon, J M; Anderson, T; Issaragrisil, S; Wiholm, B E; Young, N S; Leaverton, P; Levy, M; Shapiro, S

Kaufman, D W; Kelly, J P; Jurgelon, J M; Anderson, T; Issaragrisil, S; Wiholm, B E; Young, N S; Leaverton, P; Levy, M; Shapiro, S.

Affiliation

Kaufman DW; Slone Epidemiology Unit, Boston University School of Medicine, MA 02146, USA.

Eur J Haematol Suppl ; 60: 23-30, 1996.

Article in En | MEDLINE | ID: mdl-8987237

Subject(s)

Agranulocytosis/chemically induced; Anemia, Aplastic/chemically induced; Agranulocytosis/epidemiology; Anemia, Aplastic/epidemiology; Case-Control Studies; Europe/epidemiology; Humans; Incidence; Israel/epidemiology; Risk Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Agranulocytosis / Anemia, Aplastic Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia / Europa Language: En Journal: Eur J Haematol Suppl Year: 1996 Document type: Article

Search on Google

XML

PubMed Links